In 2023, approximately 73 million Americans with Affordable Care Act plans faced claim denials, a significant rise attributed to health insurers increasingly using artificial intelligence (AI) in their processing systems. With less than 1% opting to appeal due to the complex nature of the process, AI tools are emerging to aid patients in challenging these rejections. Jennifer Oliva, a law professor at Indiana University, highlights that while 71% of insurers use AI for utilization management, it raises concerns of transparency and fairness. The burgeoning AI arms race could lead to more sophisticated denial tactics by insurers. Meanwhile, new software is enabling patients to quickly generate appeal letters at a nominal cost. Yet, regulatory oversight remains minimal, allowing insurers to potentially exploit these systems further. The ongoing dialogue emphasizes the need for enhanced regulation to ensure AI decisions are fair and transparent, thus safeguarding patient rights and access to necessary healthcare services.
Source link
Share
Read more